Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Holders of 5% or more of ELDN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Eledon Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Eledon Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Eledon Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 20266:03 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.54 ppfrom 5.54%Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:27 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2025 | SEC |
| Feb 13, 20264:15 PM ET | Coastlands Capital LPand 4 others | 13G/A | 4.99%3.94M shares | −0.99 ppfrom 5.98%Below 5% | Dec 31, 2025 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G/A | 4.60%3.63M shares | −0.80 ppfrom 5.40%Below 5% | Dec 31, 2025 | SEC |
| Nov 24, 20253:28 PM ET | Coastlands Capital LPand 4 others | 13G | 5.98%4.76M shares | New | Nov 19, 2025 | SEC |
| Jul 29, 20251:13 PM ET | Vanguard Group Inc | 13G | 5.54%3.32M shares | New | Jun 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G | 5.40%3.25M shares | New | Jun 30, 2025 | SEC |
| Feb 14, 20255:34 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%3.14M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 202511:22 AM ET | Frazier Life Sciences Public Fund, L.P.and 16 others | 13G/A | 2.00%1.18M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Eledon Pharmaceuticals, Inc. shares.
No Form 144 notices for Eledon Pharmaceuticals, Inc. are on file.